Advanced Malignancies Clinical Trials

A listing of Advanced Malignancies medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 808 clinical trials
Study of IBI323 in Patients With Advanced Malignancies

The purpose of this study is to evaluate safety, tolerability and efficacy of IBI323(anti-LAG-3/PD-L1) or in combination with chemotherapy in participants with advanced malignancies. Another

  • 0 views
  • 18 Sep, 2021
  • 1 location
A Clinical Study of MIL95 in Advanced Malignancies.

This study is composed of two stages: Part A initial dose escalation and Part B maintenance dose escalation. Both parts will adopt the classical 3+3 dose escalation design. The starting dose for phase Ia part A is 0.1 mg/kg QW, followed by 3 dose cohorts (0.3mg/kg QW, 0.8mg/kg QW and …

  • 0 views
  • 23 Mar, 2022
  • 1 location
A Study of AK112 in Advanced Malignant Tumors

chemotherapy in advanced malignant tumors

  • 0 views
  • 25 Mar, 2022
  • 1 location
Study of LM-102 in Subjects in Advanced Tumors

This is a phase Ⅰ, first-in-human, open-label, dose escalation study to evaluate the safety and tolerability, PK, immunogenicity and preliminary anti-tumor activity of LM-102 injection in subjects with CLDN18.2-positive advanced solid tumors.

  • 0 views
  • 11 Mar, 2022
  • 6 locations
Study of LM-061 in Subjects in Advanced Tumors

This is a phase I, open-label, dose escalation study to evaluate the safety, tolerability, PK, and preliminary efficacy of LM-061 in subjects with advanced tumors.

  • 1 views
  • 24 Mar, 2022
  • 1 location
Study of E7386 in Participants With Selected Advanced Neoplasms

This study will be conducted to assess the safety/tolerability profile of E7386 as a single agent administered orally in participants with selected advanced or recurrent neoplasms and to determine the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of E7386.

  • 54 views
  • 29 Jan, 2022
  • 3 locations
A Study of HRS2543 in Patients With Advanced Tumors

To assess the safety and tolerability of HRS2543 in patients with advanced tumors and to determine the recommended phase II dose (RP2D) of HRS2543

  • 0 views
  • 25 Mar, 2022
Clinical Study of JS201 in Patients With Advanced Malignant Tumors

in the patients with advanced malignant tumors who have progression after or during the standard of care, or no effective standard therapeutic regimen. This study is divided into three phases: dose

  • 0 views
  • 24 Apr, 2022
  • 2 locations
Self-affirmation Intervention for People Newly Diagnosed With Advanced Cancer

researcher for 4 weeks. Study outcomes will be assessed at baseline, 2-, 6- and 8-weeks post baseline. It is hypothesized that self-affirmation at the time following a diagnosis of an advanced cancer by

primary cancer
advanced cancer
solid tumor
cancer diagnosis
  • 0 views
  • 14 Jun, 2022
  • 2 locations
A Phase I Open-label Study for Subjects With Advanced Malignancies

This is a first-in-human (FIH) Phase 1 dose escalation study to evaluate the safety, tolerability, PK, PD, and preliminary activity of PT01 administered IV in subjects with advanced malignancies

  • 0 views
  • 22 Aug, 2021
  • 3 locations